Prieels Pharma

Oud-Heverlee ·KBO/BCE: BE 0787.996.326

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	07-08-2025	7 d late	2025-00363822
31-12-2023	31-07-2024	28-06-2024	33 d early	2024-00187928
31-12-2022	31-07-2023	18-08-2023	18 d late	2023-00340386

Metric	This company	Sector median	Position in the sector
Solvency	14.8%	20.4%	better than 44% of 6698 sector peers
Net result	€14k	€4k	better than 68% of 6678 sector peers
Equity	€41k	€16k	better than 68% of 6712 sector peers
Gross operating margin	€19k	€24k	better than 45% of 6657 sector peers
Total assets	€276k	€94k	better than 79% of 6702 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€276k
Fixed assets	21/28	€546
Tangible fixed assets	22/27	€546
Current assets	29/58	€275k
Amounts receivable within one year	40/41	€41k
Cash & bank	54/58	€234k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€276k
Equity	10/15	€41k
Contributions / capital	10/11	€3k
Reserves	13	€25k
Accumulated profits (losses)	14	€13k
Amounts payable	17/49	€235k
Amounts payable after one year	17	€225k
Amounts payable within one year	42/48	€10k
Trade debts payable within one year	44	€1k
Income statement
Gross operating margin	9900	€19k
Operating result	9901	€18k
Financial income	75	€280
Financial charges	65	€60
Result before taxes	9903	€18k
Income taxes	67/77	€5k
Net result for the period	9904	€14k
Result to be appropriated	9905	€14k

Summary